Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancers|March 28, 2025
Opportunities and Challenges in Antibody-Drug Conjugates for Cancer Therapy: A New Era for Cancer TreatmentIdil Buyukgolcigezli, Ates Kutay Tenekeci, Ibrahim Halil SahinFuture Oncology (London, England)|October 3, 2024
An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancerAtes Kutay Tenekeci, Ahmet Arda Unal, Furkan Ceylan, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 15, 2025
Comprehensive management strategies for amivantamab-induced toxicities and review of the literatureFurkan Ceylan, Gamze Sonmez, Ates Kutay Tenekeci, et al.Frontiers of Medicine|November 28, 2024
Recurrent eosinophilia with a novel homozygous ARPC1B mutationGamze Sonmez, Baris Ulum, Ates Kutay Tenekeci, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 27, 2025
Five Patients With Two Novel Homozygous Variants in CD3 Subunits and Comprehensive Review of the LiteratureGamze Sonmez, Alp Kazancıoglu, Yigit Yazarkan, et al.Biomolecules|January 8, 2025
A Phosphatidyl Conjugated Telomerase-Dependent Telomere-Targeting Nucleoside Demonstrates Colorectal Cancer Direct Killing and Immune SignalingMerve Yilmaz, Sibel Goksen, Ilgen Mender, et al.Expert Review of Anticancer Therapy|April 9, 2025
The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancerFurkan Ceylan, Safa Can Efil, Didem Şener Dede, et al.Pageof 1